(Side note: For a person who slams this company and has no financial interest now, or ever will, as stated by the irritant, he sure follows events within Biocurex closely and faithfully. But again, he's proven time and again that what he states and the truth, could be entirely polar opposites.)

It is interesting to note that I have researched whether any other company has a universal cancer marker specifically for dogs, and I came up with "Cero". This will indeed attract a lot of use, because independent of knowing categorically what type of cancer is present, a pet owner is going to want to know whether or not their pet has "cancer" at all. If the Vet explains "the prevalence of cancer in dogs is above 50%", this test will likely be accepted if offered in addition to the regular blood work regiment for a nominal charge of, let's say, $20.00. No big deal right? Out of love and concern it will be a slam dunk sell. Perhaps Vets can follow a script when presenting the offer that will be hard for the pet owner to resist.

Also, when this hits the market for dogs, in the near future, it is going to attract media attention and will be an excellent precursor to the recaf test soon to be available for humans. The public will already be exposed to recaf by the "buzz" generated by Vets and owners the world over!

I predict this stock to hit at least $3.50 @ some point in 2010. We are going to have revenue to support increased research and development in diagnosis, imaging and therapy. There should be plenty of positive news coming out. I believe advances are going to be occurring lightning fast as compared to the past couple of years we've had to endure, and the stock price is going to be a reflection of that!